Please assess the completion status of the following clinical trial:

Trial Title: Validation of Metrological Properties of Lymphoqol

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Primary lymphedema, stage 2 or 3 ISL~Exclusion Criteria:~* Primary lymphedema stage 1, secondary lymphedema, Minimum 6 years, maximum 25

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 25 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).